News

After losing movement at 16, Audrey Crews used Neuralink to write her name via mind control. Musk says most don’t realize ...
With 22% of service robot shipment, the firm’s Shanghai debut has an ecosystem strategy- pairing humanoids with delivery and medical robots.
Researchers at Johns Hopkins University have developed SRT-H, an AI that autonomously guided a da Vinci robot through complex ...
Study offers an important advancement in understanding symptom dynamics during the menopause transition, particularly by challenging the dominance of menstrual-based staging. Although criteria such as ...
A laundry-stealing cat with expensive taste has puzzled and delighted a neighborhood in Auckland, New Zealand, by committing ...
A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...
We thank Sara Osborne and colleagues for their interest in our trial.1 Ligelizumab phase 3 studies in patients with chronic spontaneous urticaria (CSU)1 were done with a study design and in ...
Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...
Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company” or “Rakovina”) a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery ...
A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.
Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion)Regulatory submissions underway for zongertinib and nerandomilast, with ...